logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate CAS 160844-75-7

Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate CAS 160844-75-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 160844-75-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
160844-75-7
Appearance ::
White Powder
Molecular Formula::
C18H20N2O3S
Molecular Weight::
344.428
EINECS NO::
927-913-5
MDL NO::
MFCD09833701
CAS NO::
160844-75-7
Appearance ::
White Powder
Molecular Formula::
C18H20N2O3S
Molecular Weight::
344.428
EINECS NO::
927-913-5
MDL NO::
MFCD09833701
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate CAS 160844-75-7

Product Description:

Product Name:Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate CAS 160844-75-7

 

 

 

 

 

 

 

Synonyms:

ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate;

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance : white powder

Assay :≥99.0%

Density:1.22g/cm3

Boiling Point:497.15℃ at 760 mmHg

Flash Point:254.47℃

 

 

 

 

 

 

 

 

Febuxostat intermediate;

 

Febuxostat is a new generation of non purine selective xanthine oxidase inhibitors in the world. It can reduce the synthesis of uric acid and the concentration of uric acid through highly selective action on the oxidase, so as to effectively treat ventilation diseases.

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.